![Ben Slager](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ben Slager
Directeur/Membre du Conseil chez Metabolomic Technologies, Inc.
Profil
Ben Slager currently works as a Director at Metabolomic Technologies, Inc.
Postes actifs de Ben Slager
Sociétés | Poste | Début |
---|---|---|
Metabolomic Technologies, Inc.
![]() Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Metabolomic Technologies, Inc.
![]() Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Commercial Services |